By my understanding, FDA feedback is due on the Pre-Investigational New Drug (Pre-IND) meeting ( guaranteed ) by next Tuesday (FDA has committed to provide written responses by 13 February 2024) , and first dose on extension study must be any day.
2 bits of news , literally, at any moment ... wouldn't you wait for these to drop, at the very least, and sell into that news.
Go figure ....
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-17
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $94.80M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $140.9K | 586.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12010 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 4.08 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 23.5¢ | 164909 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PAA (ASX) Chart |